Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, Moshe Sade-Feldman et al.|Nature Communications|2017Cited by 201
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Yardena Samuels, Joo Sang Lee et al.|Nature Communications|2020Cited by 156
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Moshe Oren, Giuseppe Mallel et al.|Proceedings of the National Academy of Sciences|2021Cited by 113
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yardena Samuels, Yochai Wolf et al.|Cancer Discovery|2018Cited by 100
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFRSoma Ghosh, Yosef Yarden, Nishanth Belugali Nataraj et al.|Cell Reports|2021Cited by 44